Neville Rodie & Shaw’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.4M | Sell |
88,895
-17,684
| -17% | -$3.8M | 1.45% | 17 |
|
|
2026
Q1 | $23.2M | Buy |
106,579
+4,570
| +4% | +$1.01M | 1.68% | 15 |
|
|
2025
Q4 | $23.3M | Buy |
102,009
+18,004
| +21% | +$4.1M | 1.65% | 16 |
|
|
2025
Q3 | $19.5M | Sell |
84,005
-175
| -0.2% | -$35.6K | 1.41% | 19 |
|
|
2025
Q2 | $15.6M | Sell |
84,180
-7,335
| -8% | -$1.36M | 1.16% | 24 |
|
|
2025
Q1 | $19.2M | Sell |
91,515
-5,115
| -5% | -$994K | 1.5% | 18 |
|
|
2024
Q4 | $17.2M | Sell |
96,630
-4,285
| -4% | -$788K | 1.25% | 22 |
|
|
2024
Q3 | $19.9M | Buy |
100,915
+5,172
| +5% | +$965K | 1.47% | 20 |
|
|
2024
Q2 | $16.4M | Buy |
95,743
+762
| +0.8% | +$126K | 1.25% | 22 |
|
|
2024
Q1 | $17.3M | Sell |
94,981
-1,288
| -1% | -$222K | 1.32% | 21 |
|
|
2023
Q4 | $14.9M | Sell |
96,269
-1,651
| -2% | -$241K | 1.22% | 22 |
|
|
2023
Q3 | $14.6M | Sell |
97,920
-2,000
| -2% | -$294K | 1.3% | 22 |
|
|
2023
Q2 | $13.5M | Sell |
99,920
-21,820
| -18% | -$3.2M | 1.16% | 24 |
|
|
2023
Q1 | $19.4M | Sell |
121,740
-895
| -0.7% | -$137K | 1.76% | 13 |
|
|
2022
Q4 | $19.8M | Sell |
122,635
-476
| -0.4% | -$73K | 1.86% | 11 |
|
|
2022
Q3 | $16.5M | Sell |
123,111
-517
| -0.4% | -$74.2K | 1.62% | 15 |
|
|
2022
Q2 | $18.9M | Sell |
123,628
-2,086
| -2% | -$319K | 1.7% | 12 |
|
|
2022
Q1 | $20.5M | Sell |
125,714
-193
| -0.2% | -$28K | 1.52% | 17 |
|
|
2021
Q4 | $17M | Sell |
125,907
-990
| -0.8% | -$117K | 1.21% | 26 |
|
|
2021
Q3 | $13.7M | Sell |
126,897
-475
| -0.4% | -$54.3K | 1.06% | 31 |
|
|
2021
Q2 | $14.3M | Sell |
127,372
-392
| -0.3% | -$44.1K | 1.11% | 29 |
|
|
2021
Q1 | $13.8M | Sell |
127,764
-2,424
| -2% | -$259K | 1.15% | 29 |
|
|
2020
Q4 | $13.9M | Sell |
130,188
-5,758
| -4% | -$553K | 1.21% | 25 |
|
|
2020
Q3 | $11.9M | Buy |
135,946
+8,320
| +7% | +$783K | 1.12% | 27 |
|
|
2020
Q2 | $12.5M | Buy |
127,626
+30,307
| +31% | +$2.67M | 1.29% | 21 |
|
|
2020
Q1 | $7.42M | Buy |
97,319
+11,575
| +13% | +$986K | 0.9% | 37 |
|
|
2019
Q4 | $7.59M | Sell |
85,744
-75
| -0.1% | -$6.23K | 0.74% | 44 |
|
|
2019
Q3 | $6.5M | Sell |
85,819
-2,400
| -3% | -$165K | 0.69% | 46 |
|
|
2019
Q2 | $6.42M | Sell |
88,219
-10,734
| -11% | -$844K | 0.68% | 48 |
|
|
2019
Q1 | $7.97M | Sell |
98,953
-11,206
| -10% | -$917K | 0.85% | 35 |
|
|
2018
Q4 | $10.2M | Sell |
110,159
-1,950
| -2% | -$171K | 1.23% | 21 |
|
|
2018
Q3 | $10.6M | Sell |
112,109
-2,341
| -2% | -$222K | 1.05% | 28 |
|
|
2018
Q2 | $10.6M | Sell |
114,450
-4,570
| -4% | -$446K | 1.12% | 25 |
|
|
2018
Q1 | $11.3M | Sell |
119,020
-2,553
| -2% | -$280K | 1.24% | 22 |
|
|
2017
Q4 | $11.8M | Sell |
121,573
-4,650
| -4% | -$438K | 1.24% | 24 |
|
|
2017
Q3 | $11.2M | Sell |
126,223
-2,975
| -2% | -$226K | 1.25% | 23 |
|
|
2017
Q2 | $9.37M | Sell |
129,198
-14,630
| -10% | -$984K | 1.07% | 30 |
|
|
2017
Q1 | $9.37M | Sell |
143,828
-30,431
| -17% | -$1.91M | 1.07% | 29 |
|
|
2016
Q4 | $10.9M | Sell |
174,259
-8,550
| -5% | -$522K | 1.29% | 20 |
|
|
2016
Q3 | $11.5M | Sell |
182,809
-2,627
| -1% | -$170K | 1.36% | 17 |
|
|
2016
Q2 | $11.5M | Sell |
185,436
-8,110
| -4% | -$494K | 1.38% | 12 |
|
|
2016
Q1 | $11.1M | Sell |
193,546
-8,411
| -4% | -$469K | 1.34% | 16 |
|
|
2015
Q4 | $12M | Sell |
201,957
-12,086
| -6% | -$696K | 1.44% | 14 |
|
|
2015
Q3 | $11.6M | Buy |
214,043
+21,550
| +11% | +$1.4M | 1.43% | 16 |
|
|
2015
Q2 | $12.9M | Buy |
192,493
+24,931
| +15% | +$1.63M | 1.42% | 15 |
|
|
2015
Q1 | $9.81M | Sell |
167,562
-4,969
| -3% | -$300K | 1.02% | 26 |
|
|
2014
Q4 | $11.3M | Buy |
172,531
+21,225
| +14% | +$1.34M | 1.14% | 24 |
|
|
2014
Q3 | $8.74M | Buy |
151,306
+75,143
| +99% | +$4.17M | 0.86% | 34 |
|
|
2014
Q2 | $4.3M | Buy |
76,163
+9,948
| +15% | +$522K | 0.43% | 70 |
|
|
2014
Q1 | $3.4M | Sell |
66,215
-1,675
| -2% | -$84.7K | 0.37% | 74 |
|
|
2013
Q4 | $3.58M | Buy |
67,890
+4,846
| +8% | +$238K | 0.39% | 72 |
|
|
2013
Q3 | $2.82M | Sell |
63,044
-1,500
| -2% | -$66.5K | 0.33% | 78 |
|
|
2013
Q2 | $2.67M | Buy |
+64,544
| New | +$2.82M | 0.32% | 78 |
|
Other funds holding ABBV
ATO
Neville Rodie & Shaw's ABBV Position: Q2 2026 in Review
Neville Rodie & Shaw reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $3.8M and leaving 88,895 shares worth $22.4M. The position accounts for 1.45% of the portfolio, ranked #17.
Neville Rodie & Shaw first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.3M in Q4 2025. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Neville Rodie & Shaw held 88,895 shares of AbbVie worth $22.4M as of Q2 2026.
- Neville Rodie & Shaw sold 17,684 AbbVie shares in Q2 2026, an estimated $3.8M.
- AbbVie made up 1.45% of Neville Rodie & Shaw's portfolio in Q2 2026, its #17 holding.
- Neville Rodie & Shaw first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Neville Rodie & Shaw's AbbVie position peaked at $23.3M in Q4 2025.
- 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.